Pharmacokinetics and pharmacodynamics of intranasal insulin administered to healthy subjects in escalating doses

Diabetes Technology and Therapeutics

Volumn 7, Issue 1, 2005, Pages 124-130

  Leary, Andrew C ^a,b   Stote, Robert M ^c   Breedt, H J ^b   O'Brien, Jackie ^b   Buckley, Brendan ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Shandon Clinic Cork Ireland   (Ireland)

^c Bentley Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; C-PEPTIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INSULIN; KINETICS; MALE; REFERENCE VALUES;

EID: 14844341253     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2005.7.124     Document Type: Article

References (8)

1. Paquot N, Scheen AJ, Franchimont P, Lefebvre PJ: The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man. Diabetes Metab 1998;14:31-36.
2. Drejer K, Vaag A, Bech K, Hansen P, Sorensen AR, Mygind N: Intranasal administration of insulin with phospholipid as absorption enhancer: phamacokinetics in normal subjects. Diabet Med 1992;9:335-340.
3. Newman SP, Steed KP, Hardy JG, Wilding IR, Hooper G, Sparrow RA: The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques. J Pharm Pharmacol 1994;46:657-660.
4. Haruta S, Hanafusa T, Fukase H, Miyajima H, Oki T: An effective absorption behavior of insulin for diabetic treatment following intranasal delivery using porous spherical calcium carbonate in monkeys and healthy human volunteers. Diabetes Technol Ther 2003;5:1-9.
5. Moses AC, Gordon GS, Carey MC, Flier JS: Insulin administered intranasally as an insulin-bile salt aerosol: effectiveness and reproducibility in normal and diabetic subjects. Diabetes 1983;32:1040-1047.
6. Coates PA, Ismail IS, Luzio SD, Griffiths I, Ollerton RL, Volund A, Owens DR: Intranasal insulin: the effects of three dose regimens on postprandial glycaemic profiles in type II diabetic subjects. Diabet Med 1995;12:235-239.
7. Valensi P, Zirinis P, Nicolas P, Perret G, Sandre-Banon D, Attali JR: Effect of insulin concentration on bioavailability during nasal spray administration. Pathol Biol 1996;44:235-240.
8. Hinchcliffe M, Illum L: Intranasal insulin delivery and therapy. Adv Drug Deliv Rev 1999;35:199-234.